skip to Main Content

Hard-to-Treat Pancreatic Cancer Hijacks Immune System and Could be Targeted with Immunotherapies

Hard-to-Treat Pancreatic Cancer Hijacks Immune System and Could be Targeted with Immunotherapies
Scientists have used artificial intelligence (AI) to reveal an aggressive form of pancreatic cancer that is more likely to respond to immunotherapy, in the most extensive analysis of the immune landscape of these tumours to date.

Pancreatic neuroendocrine cancer starts in cells that produce hormones such as insulin. Once it spreads, only one in four people will survive for more than five years, and new treatment options are desperately needed. Read more . . . 


Back To Top